This international , randomised , double-blind , placebo-controlled , phase @ study enrolled adults aged @-@ years with relapsing multiple sclerosis , one or more relapse in the previous @ months or two or more in the previous @ months but no relapse in the previous @ days , and an Expanded Disability Status Scale ( EDSS ) score of @ points or less .